12 Best Fundamentally Strong Penny Stocks to Buy Right Now

Page 2 of 10

9. InspireMD, Inc. (NASDAQ:NSPR)

Upside Potential as of September 19, 2025: 83.67%

According to the latest filing with the SEC, Parkman Healthcare Partners LLC has increased its position in InspireMD, Inc. (NASDAQ:NSPR) by 37.1% during the first quarter. Following the purchase of 316,700 shares, the institutional investor now owns 1,171,416 shares of the company’s stock, which translates to an ownership of nearly 3.82%.

Powered by a clear procedure-agnostic strategy, InspireMD, Inc. (NASDAQ:NSPR) is the first company to invest in the broadest toolkit of carotid procedures, strengthening not only carotid artery stenting, commonly known as CAS, but also transcarotid artery revascularization, known as TCAR.

The company’s ongoing hiring plans aren’t something hidden. With a stellar team of sales and clinical support specialists, InspireMD, Inc. (NASDAQ:NSPR) has already begun to see its engagement enhanced and market position strengthened. A testament to this is the company’s recent appointment of Mike Lawless as the new CFO, who brings decades of financial stewardship and a strong commitment to InspireMD’s mission.

InspireMD, Inc. (NASDAQ:NSPR) is a Florida-based medical device company that develops and commercializes treatments for carotid artery and other vascular diseases. The core offerings of this company include CGuard carotid embolic prevention system (EPS), CGuard Prime Stent System, and SwitchGuard neuroprotection system.

Page 2 of 10